Under construction – not a live service
Sign in
Taking people in FranceNo phase

Studies motor skill differences in children with autism spectrum disorder

Tests movement, hand skills and eye movements in children aged 6 to 11 with autism.

Plain-language title generated from the registry record
Registry title: Better Understand Motor Deficits Associated With Autism Spectrum Disorders: Development of an Assessment Protocol

Key facts

Where
Bordeaux, La Rochelle, Limoges, and Poitiers, FranceSee the 4 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 6 and 11 years old?

Source: NCT05236803, who can take part

Where in France

  • Centre Hospitalier Charles PerrensBordeaux, FranceTaking people
  • Centre Hospitalier La Rochelle Re AunisLa Rochelle, FranceTaking people
  • CHU de LimogesLimoges, FranceTaking people
  • Centre Hospitalier Henri LaboritPoitiers, FranceTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Centre Hospitalier Charles Perrens, Bordeaux
Trial code
NCT05236803
Record updated
16 March 2026
Original description
This research is a case-control study aiming to characterize motor peculiarities (objective quantitative and qualitative measures) and its psycho-physiological correlates of children with ASD.Read full original descriptionShow less

Better Understand Motor Deficits Associated With Autism Spectrum Disorders: Development of an Assessment Protocol

This research is a case-control study aiming to characterize motor peculiarities (objective quantitative and qualitative measures) and its psycho-physiological correlates of children with ASD.

Inclusion: All participants :; Be between 6 and 11 years old; Mastery of the French language; Be affiliated with a Social Security scheme or benefit from affiliation by a third person; Both parents (or the holder of legal authority) have read, understood and signed the study consent; Be affiliated with social security; Participants with ASD should also verify the following inclusion criteria:; Being diagnosed with ASD (DSM-V).

Exclusion: To have concomitant psychotropic drug treatments not stabilized, initiated in the last 2 months: antipsychotics, mood stabilizers, anti-epileptics, psychostimulants, antidepressants; Have diagnosed neurological or psychiatric disorders, present a general or metabolic pathology having a known impact on the child's motor skills (eg: Epilepsy, Tics and Gilles de la Tourette Syndrome, Intellectual Deficiency, Neuromuscular Syndrome, Metabolic Neurological Syndrome , neoplasms); Participant with ADHD (Attention Deficit Disorder with or without Hyperactivity) or CDD (Developmental Coordination Disorder); All participants :; Refusal to participate in the research on the part of the participant and / or holders of parental authority; Be a person benefiting from enhanced protection, namely : persons deprived of their liberty by a judicial or administrative decision, persons staying in a health or social establishment; Have uncorrected visual or hearing problems; Have a motor handicap of the upper or lower limbs, fitted or not; Suspicion of low intellectual efficiency if at least one of the two subtests (Similarities or Matrices) of WISC V (retrieved from the medical file if the TSA participant) presents a result (standard score) strictly lower than 7; Participants without ASD :.

ClinicalTrials.gov NCT05236803